Juniper Pharmaceuticals, Inc. EBITDA Margin 2010-2018 | JNP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Juniper Pharmaceuticals, Inc. (JNP) over the last 10 years. The current EBITDA margin for Juniper Pharmaceuticals, Inc. as of June 30, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-06-30 | $0.06B | 0 | 0.00% |
| 2018-03-31 | $0.06B | $0.00B | 1.82% |
| 2017-12-31 | $0.05B | $-0.00B | -4.00% |
| 2017-09-30 | $0.06B | $0.01B | 13.56% |
| 2017-06-30 | $0.06B | $0.01B | 17.24% |
| 2017-03-31 | $0.06B | $0.01B | 14.29% |
| 2016-12-31 | $0.06B | $0.01B | 14.55% |
| 2016-09-30 | $0.04B | $-0.00B | -6.98% |
| 2016-06-30 | $0.04B | $-0.00B | -7.14% |
| 2016-03-31 | $0.04B | $-0.00B | -2.50% |
| 2015-12-31 | $0.04B | 0 | 0.00% |
| 2015-09-30 | $0.04B | $0.00B | 7.89% |
| 2015-06-30 | $0.04B | $0.01B | 15.38% |
| 2015-03-31 | $0.04B | $0.01B | 19.44% |
| 2014-12-31 | $0.03B | $0.01B | 20.59% |
| 2014-09-30 | $0.03B | $0.01B | 15.63% |
| 2014-06-30 | $0.03B | $0.00B | 7.41% |
| 2014-03-31 | $0.03B | $0.00B | 14.29% |
| 2013-12-31 | $0.03B | $0.01B | 18.52% |
| 2013-09-30 | $0.03B | $0.01B | 21.43% |
| 2013-06-30 | $0.03B | $0.01B | 25.00% |
| 2013-03-31 | $0.03B | $0.01B | 21.43% |
| 2012-12-31 | $0.03B | $0.00B | 15.38% |
| 2012-09-30 | $0.03B | $0.01B | 28.00% |
| 2012-06-30 | $0.02B | $0.00B | 17.39% |
| 2012-03-31 | $0.03B | $0.02B | 44.12% |
| 2011-12-31 | $0.04B | $0.02B | 54.76% |
| 2011-09-30 | $0.05B | $0.03B | 52.94% |
| 2011-06-30 | $0.06B | $0.03B | 48.33% |
| 2011-03-31 | $0.05B | $0.02B | 32.00% |
| 2010-12-31 | $0.05B | $0.01B | 13.33% |
| 2010-09-30 | $0.04B | $-0.00B | -7.69% |
| 2010-06-30 | $0.03B | $-0.01B | -15.15% |
| 2010-03-31 | $0.03B | $-0.01B | -18.75% |
| 2009-12-31 | $0.03B | $-0.00B | -12.50% |
